Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  AcelRx Pharmaceuticals Inc    ACRX

ACELRX PHARMACEUTICALS INC

(ACRX)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

ACELRX PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 05:35pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.





On January 8, 2019, John Saia, General Counsel of AcelRx Pharmaceuticals, Inc. (the "Company"), notified the Company of his resignation from all positions with the Company effective immediately.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ACELRX PHARMACEUTICALS INC
03/12ACELRX PHARMACEUTICALS : to Present at Oppenheimer and Co. Inc. 29th Annual Heal..
AQ
03/11ACELRX PHARMACEUTICALS : to Present at Oppenheimer & Co. Inc. 29th Annual Health..
PR
03/07ACELRX PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
AQ
03/07ACELRX PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fina..
AQ
03/07ACELRX PHARMACEUTICALS : Announces Commercial Launch of DSUVIA and Reports Fourt..
PR
02/25ACELRX PHARMACEUTICALS : to announce fourth quarter 2018 results and provide a c..
AQ
02/22ACELRX PHARMACEUTICALS : to announce fourth quarter 2018 results and provide a c..
PR
02/14ACELRX PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K..
AQ
02/01ACELRX PHARMACEUTICALS : Pharmaceutical's sufentanil sublingual tablet to be hig..
AQ
01/31ACELRX PHARMACEUTICALS : Pharmaceutical's sufentanil sublingual tablet (DSUVIA) ..
PR
More news